ACTIVE

LYS MEDICAL

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,1 M €-15,9 %over 1 year
Gross margin-309,2 k €-231,2 %over 1 year
Equity116 k €+131,1 %over 1 year

Identity

Source · BCE/KBO

LYS MEDICAL is a Public limited company incorporated in 2018. Its main activity is: Computer programming activities. Its registered office is in Charleroi.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0688.626.061
Incorporation
18/01/2018
Legal form
Public limited company
Registered office
Rue Clément Ader 10
6041 Charleroi · WallonieSee on map
Contributed capital
1 598 808,12 €
Latest accounts
31/12/2025
Joint committees (1)
  • 200
Contacts
1 public detail availableLog in to view
Signals
Healthy social debts

Financials

Source · NBB, 8 filings

Trend over 6 financial years

20252024202320222021
Income statement
Gross margin-309,2 k €-93,4 k €-302,7 k €-232,9 k €-9,3 k €
EBITDA-820,5 k €-530,9 k €-912,3 k €-862,3 k €-413,4 k €
Operating result-1,2 M €-1 M €-1,4 M €-1,3 M €-768,9 k €
Net result-1,1 M €-990 k €-1,3 M €-1,1 M €-638,8 k €
Balance sheet
Equity116 k €-373,5 k €940,9 k €1,4 M €854,4 k €
Total assets1,3 M €1,5 M €2,2 M €2,5 M €1,9 M €
Cash323,4 k €154,4 k €473,6 k €842,1 k €664,1 k €
Debts1,1 M €1,9 M €1,2 M €1 M €1,1 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 28 ended

Active mandates

Olivier Fructus

Director · since 27 juin 2024 · until 27 juin 2030

Active
CANA

Director · since 10 juillet 2023 · until 10 mai 2027 · 0734.717.392

Represented by Prignon Anne

Active
Devière Jacques

Director · since 10 juillet 2023 · until 10 mai 2027

Active
Mertens Benjamin

Managing director · since 10 juillet 2023 · until 10 mai 2027

Active
Sylvain Landau

Director · since 10 juillet 2023 · until 10 mai 2027

Active

Ended mandates

Olivier Fructus

Director · since 14 septembre 2023 · until 27 juin 2024

Ended
CANA

Director · since 10 juillet 2023 · until 10 mai 2027 · 0734.717.392

Represented by Prignon ANNE

Ended
Devière Jacques

Chairman of the board of directors · since 10 juillet 2023 · until 10 mai 2027

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 10 juillet 2023 · until 10 mai 2027 · 0667.964.566

Represented by De HALLEUX ELISABETH

Ended

Other companies at this address

Rue Clément Ader 10 6041 Charleroi
CompanyCBE no.
2 Bridge WL● Active
1003.906.745
3D Fibroscreen● Active
1022.772.354
AdipoPharma Belgique● Active
1008.146.338
ATRYON BELGIUM● Active
0751.698.530
Brussels South Charleroi BioPark Dev● Active
0479.250.670
ConvEyXo● Active
0725.874.259
CONVEYXO GROUP● Active
1016.957.797
ELKEDONIA BELGIUM● Active
1021.635.177
ENDO TOOLS THERAPEUTICS● Active
0807.570.233
Enodia Therapeutics Belgium● Active
1039.324.811
EU BIOTECH CAMPUS● Active
0776.668.706
Exo-Harvest● Active
0803.425.264
Hemastatx● Active
1019.406.058
Immunofusion● Active
0804.563.629
ImmunXperts● Active
0552.755.587
INCHINN THERAPEUTICS● Active
0799.914.755
INSTAR BELGIQUE● Active
1039.395.085
KOKUMA● Active
0799.078.377
MILEUTIS● Active
1011.400.984
Nexelis Europe● Active
0744.498.061

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/06/202601/08/202526/08/202409/08/202317/08/202209/07/2021
General meeting18/06/202626/06/202527/06/202410/07/202317/06/202202/07/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202518/06/202622/06/2026FrenchPDF
Micro model31/12/202426/06/202501/08/2025FrenchPDF
Micro model31/12/202327/06/202426/08/2024FrenchPDF
Micro model31/12/202210/07/202309/08/2023FrenchPDF
Micro model31/12/202117/06/202217/08/2022FrenchPDF
Micro model31/12/202002/07/202109/07/2021FrenchPDF
Micro model31/12/201919/06/202010/09/2020FrenchPDF
Micro model31/12/201824/06/201927/06/2019FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 28 ended

Active mandates

Olivier Fructus

Director · since 27 juin 2024 · until 27 juin 2030

Active
CANA

Director · since 10 juillet 2023 · until 10 mai 2027 · 0734.717.392

Represented by Prignon Anne

Active
Devière Jacques

Director · since 10 juillet 2023 · until 10 mai 2027

Active
Mertens Benjamin

Managing director · since 10 juillet 2023 · until 10 mai 2027

Active
Sylvain Landau

Director · since 10 juillet 2023 · until 10 mai 2027

Active

Ended mandates

Olivier Fructus

Director · since 14 septembre 2023 · until 27 juin 2024

Ended
CANA

Director · since 10 juillet 2023 · until 10 mai 2027 · 0734.717.392

Represented by Prignon ANNE

Ended
Devière Jacques

Chairman of the board of directors · since 10 juillet 2023 · until 10 mai 2027

Ended
FONDS DE CAPITAL A RISQUE 2020

Director · since 10 juillet 2023 · until 10 mai 2027 · 0667.964.566

Represented by De HALLEUX ELISABETH

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Capital / shares06/01/2026
    CAPITAL, ACTIONS
    PDF
  • Capital / shares19/06/2025
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates01/03/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares20/11/2023
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates09/02/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates02/01/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office18/03/2022
    SIEGE SOCIAL
    PDF
  • Mandates25/02/2021
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,1 M €↓
  2. 2024
    Annual accounts 2024-990 k €↑
  3. 2023
    Annual accounts 2023-1,3 M €↓
  4. 2022
    Annual accounts 2022-1,1 M €↓
  5. 2021
    Annual accounts 2021-638,8 k €↓
  6. 2018
    Annual accounts 2018-8,5 k €
  7. 18/01/2018
    IncorporationPublic limited company